folic acid has been researched along with Small Cell Lung Carcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Rodríguez, E; Pandiella, A; Sanz, E | 1 |
| Christoph, DC; Hager, T; Mairinger, FD; Schmid, KW; Vollbrecht, C; Walter, RF; Werner, R; Wohlschlaeger, J | 1 |
| Bromund, JL; Chen, R; Neubauer, M; Obasaju, C; Raju, RN; Reynolds, CH; Richards, DA; Ruxer, RL; Savin, M; Smith, DA; Socinski, MA; Zhan, F | 1 |
| Lu, W; Luo, QY; Pang, DW; Shi, YB; Song, EQ; Zhang, ZL | 1 |
1 trial(s) available for folic acid and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cohort Studies; Dietary Supplements; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Prognosis; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thymidylate Synthase; Vitamin B Complex | 2008 |
3 other study(ies) available for folic acid and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.
Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Drug Compounding; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Mice; Pantothenic Acid; Plant Extracts; Proliferating Cell Nuclear Antigen; Small Cell Lung Carcinoma; Vitamin B 12; Vitamin B 6; Xenograft Model Antitumor Assays; Zinc Sulfate | 2018 |
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Folic Acid; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Young Adult | 2016 |
Tumor cell targeting using folate-conjugated fluorescent quantum dots and receptor-mediated endocytosis.
Topics: Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Endocytosis; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; KB Cells; Lung Neoplasms; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron, Transmission; Polyethylene Glycols; Quantum Dots; Receptors, Cell Surface; Small Cell Lung Carcinoma | 2009 |